化学
EZH2型
体内
泛素
降冰片烯
间变性淋巴瘤激酶
蛋白质降解
增强子
体外
下调和上调
蛋白酶体
癌症研究
生物化学
表观遗传学
生物
转录因子
医学
基因
外科
生物技术
单体
有机化学
聚合物
恶性胸腔积液
胸腔积液
作者
Shaowen Xie,Feiyan Zhan,Jingjie Zhu,Yuan Sun,Huajian Zhu,Jie Liu,Jian Chen,Zheying Zhu,Dong‐Hua Yang,Zhe‐Sheng Chen,Hong Yao,Jinyi Xu,Shengtao Xu
出处
期刊:Angewandte Chemie
[Wiley]
日期:2023-01-21
卷期号:62 (13): e202217246-e202217246
被引量:75
标识
DOI:10.1002/anie.202217246
摘要
Hydrophobic tagging (HyT) is a potential therapeutic strategy for targeted protein degradation (TPD). Norbornene was discovered as an unprecedented hydrophobic tag in this study and was used to degrade the anaplastic lymphoma kinase (ALK) fusion protein by linking it to ALK inhibitors. The most promising degrader, Hyt-9, potently reduced ALK levels through Hsp70 and the ubiquitin-proteasome system (UPS) in vitro without compensatory upregulation of ALK. Furthermore, Hyt-9 exhibited a significant tumor-inhibiting effect in vivo with moderate oral bioavailability. More importantly, norbornene can also be used to degrade the intractable enhancer of zeste homolog 2 (EZH2) when tagged with the EZH2 inhibitor tazemetostat. Thus, the discovery of novel hydrophobic norbornene tags shows promise for the future development of TPD technology.
科研通智能强力驱动
Strongly Powered by AbleSci AI